Literature DB >> 21091868

Impaired striatum-dependent behavior in GASP-1-knock-out mice.

C Mathis1, J-B Bott, M-P Candusso, F Simonin, J-C Cassel.   

Abstract

G protein-coupled receptor (GPCR) associated sorting protein-1 (GASP-1) is suspected to play a key role in recycling and degradation of several GPCRs. In a previous study, we have shown that GASP-1-knock-out (GASP-1-KO) mice displayed deficits in acquiring a cocaine self-administration task, associated with an exacerbated down-regulation of striatal dopaminergic and cholinergic receptors. Among several possibilities, GASP-1 deficiency could have impaired memory processes underlying the acquisition of the operant conditioning task. Therefore, the present study investigated cognitive performances of GASP-1-KO mice and their wild-type littermates (WT) in a broad variety of memory tasks. Consistent with a deficit in procedural memory, GASP-1-KO mice showed delayed acquisition of a food-reinforced bar-press task. During water-maze training in hidden- or visible-platform paradigms, mutant and WT mice acquired the tasks at the same rate. However, GASP-1 mice exhibited persistent thigmotaxic swimming, longer distance to the platform, and reduced swim speed. There was no deficit in several tasks requiring simple behavioral responses (Barnes maze, object recognition and passive avoidance tasks). Thus, the ability to acquire and/or express complex responses seems affected in GASP-1-deficient mice. Hippocampal functions were preserved, as the retention of an acquired memory in spatial tasks remained unaffected. The pattern of behavioral deficits observed in GASP-1-KO mice is coherent with current knowledge on the role of striatal GPCRs in acquisition/expression of skilled behavior and in motivation. Together with the previous findings, the so far established phenotype of GASP-1-KO mice makes them a potentially exciting tool to study striatal functions.
© 2010 The Authors. Genes, Brain and Behavior © 2010 Blackwell Publishing Ltd and International Behavioural and Neural Genetics Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21091868     DOI: 10.1111/j.1601-183X.2010.00666.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  7 in total

1.  Respiratory failure, cleft palate and epilepsy in the mouse model of human Xq22.1 deletion syndrome.

Authors:  Jian Zhou; Ethan M Goldberg; N Adrian Leu; Lei Zhou; Douglas A Coulter; P Jeremy Wang
Journal:  Hum Mol Genet       Date:  2014-02-25       Impact factor: 6.150

2.  Barnes maze testing strategies with small and large rodent models.

Authors:  Cheryl S Rosenfeld; Sherry A Ferguson
Journal:  J Vis Exp       Date:  2014-02-26       Impact factor: 1.355

3.  Loss of D2 dopamine receptor function modulates cocaine-induced glutamatergic synaptic potentiation in the ventral tegmental area.

Authors:  Anuradha Madhavan; Emanuela Argilli; Antonello Bonci; Jennifer L Whistler
Journal:  J Neurosci       Date:  2013-07-24       Impact factor: 6.167

4.  A 1.1-Mb segmental deletion on the X chromosome causes meiotic failure in male mice.

Authors:  Jian Zhou; John R McCarrey; P Jeremy Wang
Journal:  Biol Reprod       Date:  2013-06-27       Impact factor: 4.285

5.  Escape from X inactivation varies in mouse tissues.

Authors:  Joel B Berletch; Wenxiu Ma; Fan Yang; Jay Shendure; William S Noble; Christine M Disteche; Xinxian Deng
Journal:  PLoS Genet       Date:  2015-03-18       Impact factor: 5.917

6.  Abnormal mGluR-mediated synaptic plasticity and autism-like behaviours in Gprasp2 mutant mice.

Authors:  Mohamed Edfawy; Joana R Guedes; Marta I Pereira; Mariana Laranjo; Mário J Carvalho; Xian Gao; Pedro A Ferreira; Gladys Caldeira; Lara O Franco; Dongqing Wang; Ana Luisa Cardoso; Guoping Feng; Ana Luisa Carvalho; João Peça
Journal:  Nat Commun       Date:  2019-03-29       Impact factor: 14.919

7.  Striatal pre-enkephalin overexpression improves Huntington's disease symptoms in the R6/2 mouse model of Huntington's disease.

Authors:  Stéphanie Bissonnette; Mylène Vaillancourt; Sébastien S Hébert; Guy Drolet; Pershia Samadi
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.